1. Home
  2. CCCC vs SRI Comparison

CCCC vs SRI Comparison

Compare CCCC & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$1.89

Market Cap

177.4M

Sector

Health Care

ML Signal

HOLD

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$8.84

Market Cap

161.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
SRI
Founded
2015
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
177.4M
161.7M
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
CCCC
SRI
Price
$1.89
$8.84
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$7.25
$16.00
AVG Volume (30 Days)
1.4M
224.4K
Earning Date
02-27-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,108,000.00
$874,357,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$3.54
52 Week High
$3.65
$9.71

Technical Indicators

Market Signals
Indicator
CCCC
SRI
Relative Strength Index (RSI) 43.91 72.07
Support Level $1.74 $8.17
Resistance Level $1.90 $9.71
Average True Range (ATR) 0.12 0.65
MACD -0.00 0.16
Stochastic Oscillator 40.56 76.78

Price Performance

Historical Comparison
CCCC
SRI

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

Share on Social Networks: